AIM

AIM ImmunoTech
AIM

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $2.18M invested in AIM ImmunoTech in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$42.1K
2
+$41K

Top Sellers

1
-$76K
2
-$75K
3
-$69.5K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$28K
5
Citadel Advisors
Citadel Advisors
Florida
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$938K
2
$631K
3
$149K
4
$139K
5
$76K
6
$65K
7
$41K
8
$30K
9
$27K
10
$24K
11
$18K
12
$9K
13
$8K
14
$6K
15
$4K
16
$4K
17
$3K
18
$3K
19
$3K
20
$1K
21
–
22
–